Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple vs Quadruple Therapy for H. Pylori Gastritis
NCT07312721Phase 4Completed
- Start
- Jan 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bismuth subsalicylate, metronidazole and tetracycline in Helicobacter pylori infection, chronic gastritis and Peptic ulcer disease (PUD) (2 arms). Primary endpoint: Eradication of Helicobacter pylori infection. Started Jan 2024; status: completed.
02
Drugs
bismuth subsalicylatemetronidazoletetracycline
03
Conditions
Helicobacter pylori infectionchronic gastritisPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT07312721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07312721.